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Abstract
Objective The introduction of hematopoietic stem cell
transplantation (HSCT) has significantly improved the
life-span of Hurler patients (mucopolysaccharidosis type
I-H, MPS I-H). Yet, the musculoskeletal manifestations
seem largely unresponsive to HSCT. In order to facilitate
evidence based management, the aim of the current study
was to give a systematic overview of the orthopaedic
complications and motor functioning of Hurler’s patients
after HSCT.
Methods A systematic review was conducted of the
medical literature published from January 1981 to June
2010. Two reviewers independently assessed all eligible
citations, as identified from the Pubmed and Embase
databases. A pre-developed data extraction form was used
to systematically collect information on the prevalence of
radiological and clinical signs, and on the orthopaedic
treatments and outcomes.
Results A total of 32 studies, including 399 patient reports
were identified. The most frequent musculoskeletal abnor-
malities were odontoid hypoplasia (72%), thoracolumbar
kyphosis (81%), genu valgum (70%), hip dysplasia (90%)
and carpal tunnel syndrome (63%), which were often
treated surgically during the first decade of life. The overall
complication rate of surgical interventions was 13.5%.
Motor functioning was further hampered due to reduced
joint mobility, hand dexterity, motor development and
longitudinal growth.
Conclusion Stem cell transplantation does not halt the
progression of a large range of disabling musculoskeletal
abnormalities in Hurler’s disease. Although prospective
data on the quantification, progression and treatment of
these deformities were very limited, early surgical inter-
vention is often advocated. Prospective data collection will
be mandatory to achieve better evidence on the effect of
treatment strategies.
Introduction
Hurler’s disease (mucopolysaccharidosis type I, MPS I-H)
is an autosomal recessive lysosomal storage disease with an
estimated incidence of about 1/ 100,000 (Malm et al.
2008b). The disorder is caused by a deficiency of the
enzyme α-L-iduronidase (IDUA), leading to the cellular
accumulation of the glycosaminoglycans (GAGs) dermatan
and heparan sulphate. This cellular accumulation, in turn,
leads to progressive and generalised cell, tissue and organ
dysfunction. If left untreated, patients will die early of
cardiopulmonary failure (median age 6.8 years) (Moore et
al. 2008). In addition, patients will develop progressive
mental retardation, corneal clouding, hepatosplenomegaly
and dysostosis multiplex (Cleary and Wraith 1995). Dysos-
tosis multiplex refers to a broad constellation of skeletal
abnormalities such as a thickened skull, shortened long
bones, odontoid hypoplasia, vertebral abnormalities, ace-
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tabular dysplasia, genu valgum and short/ broad digits
(Aldenhoven et al. 2009). These abnormalities presumably
arise from a lack of primary ossification at several
predeliction sites, a lack of secondary bone remodelling,
and dysfunction of ligamentous structures and joint
capsules (Field et al. 1994). Histological examination of
growth plates revealed swollen vacuole-filled chondrocytes,
architectural irregularities, and failure of cartilage mineral-
ization (Silveri et al. 1991). The exact pathophysiological
mechanism underlying the bony abnormalities in Hurler’s
disease remains unclear, however.
The introduction of hematopoietic stem cell transplanta-
tion (HSCT) in 1981 by Hobbs has significantly improved
the survival and disease progression of Hurler patients
(Hobbs 1981). Following successful engraftment, the donor
cells provide a natural source of the deficient enzyme,
which results in improved cardiopulmonary symptoms,
decreased hepatosplenomegaly and an improved neuro-
developmental status (Peters and Steward 2003; Souillet et
al. 2003; Hugh-Jones 1986). As a result, treated patients
now survive into adulthood. Yet, the majority of the
musculoskeletal problems seem largely unresponsive to
HSCT, presumably due to insufficient penetration of the
donor enzyme in the skeletal tissues (Breider et al. 1989).
Due to the increased life expectancy of Hurler patients,
and the limited response of their musculoskeletal abnor-
malities to HSCT, orthopaedic problems become relevant in
the follow-up of these patients. The majority of Dutch
Hurler patients are treated at our institution, and orthopae-
dic questions regarding the optimal treatment of these
disabling musculoskeletal abnormalities have accumulated.
Although the literature and the worldwide MPS I registry
(Pastores et al. 2007) provide some answers, a systematic
overview of the prevalence, clinical course and treatment of
the various orthopaedic manifestations of Hurler’s disease
is currently lacking. Therefore, the objective of this study
was to provide a systematic review on the musculoskeletal
manifestations of Hurler’s disease after HSCT, with
emphasis on the orthopaedic treatment and outcome.
Additionally, information on aspects of motor functioning
such as gait/mobility, motor skills, joint range of motion
and longitudinal growth was systematically collected.
Methods
Search strategy
An electronic search of the literature published from
January 1981 to June 2010 was conducted in Pubmed and
Embase, by using MeSH (Medical Subject Heading, Med-
line) and EMBASE terms, as well as free text words. The
search included the terms Hurler, mucopolysaccharidosis
type I, MPS I, iduronidase deficiency, orthopaedic, ortho-
pedic, dysostosis multiplex, musculoskeletal, hip, spine,
knee, joint, bones, myelopathy, kyphosis, genu valgum,
carpal tunnel syndrome, trigger finger, odontoid, growth,
height and motor development. Two reviewers (MV and
MK) independently assessed the titles and abstracts of all
eligible citations to determine if they met the inclusion
criteria. Selected articles were then evaluated in full text by
the same two reviewers. Additional articles were sought by
reference tracking. Disagreements were resolved by means
of discussion.
Inclusion and exclusion criteria
The search strategy was confined to patients with Hurler’s
disease after hematopoietic stem cell transplantation
(HSCT) in combination with a description of the musculo-
skeletal manifestations and/or the topics: gait, motor skills,
joint range of motion (ROM), longitudinal growth and
neurological symptoms. Only original articles published
after 1981 were selected (the introduction of HSCT for
MPS by Hobbs (Hobbs 1981)). All languages were
included. Case reports and selected patient populations
were reviewed for treatment options only. Papers were
excluded if patients were not treated with HSCT, or if we
remained unsure about previous HSCT after contacting the
authors.
Data extraction
A pre-developed data extraction form was used to system-
atically collect all relevant information from the articles. All
data were scored in relation to the patient’s age and
duration of follow-up after HSCT. The orthopaedic aspects
contained the radiological and clinical signs of spinal
involvement, hip dysplasia, genu valgum, carpal tunnel
syndrome and trigger fingers. In addition, all available
information on orthopaedic treatments and outcomes was
collected. A surgical complication or adverse outcome was
defined as the need for a re-operation, a correction that was
judged insufficient by the authors (e.g. tibio-femoral angle >7°,
Odunusi et al. 1999), or the absence of an objective
improvement in disease symptoms.
Data analysis
The average prevalence of the radiological and clinical
signs of Hurler’s disease was calculated by pooling all
reported cases per topic (so called patient reports). In
addition, weighted averages of the age at HSCT and
duration of follow-up after HSCT were calculated. A
similar method was used to pool all data on treatment
options and outcome. The number of reports that were
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available for the calculation of the average age at HSCT and
follow-up after HSCT was usually somewhat smaller
compared to the number of available reports on prevalence
(data not shown). For the prevalence data, only papers on
non-selected patient cohorts were included. As a conse-
quence, five papers were excluded from this analysis; three
on CTS (17 patients referred for CTS diagnostics), one on
kyphosis (one patient referred for anterior fusion) (Dalvie et
al. 2001), and one on linear growth (eight patients treated
with growth hormone therapy) (Polgreen et al. 2009).
When reviewing the included articles, 5 studies stated
that similar patients were included in multiple papers. The
number of patients that were reported twice ranged from 2–
6. Yet, the topics and duration of follow-up differed across
the studies. All other included papers were analysed for
potential patient overlap as well. As shown in Table 1, a
large number of studies originated from a limited number of
institutions. After careful comparison, no more than two
papers with potential patient overlap per topic were
identified. Because these papers contained unique and




A total of 32 studies (31 case series and one case report)
published between 1993 and 2009 were included (see Fig. 1
for flow chart and Table 2). These studies described a total
of 399 patient reports. The vast majority of studies (29)
were longitudinal and of retrospective nature. A total of 26
studies described only Hurler patients, the other six studies
described mixed patient populations. The average age of
the patients at HSCT was 18.8±7.0 months (25 studies,
n=348 patients, range across studies 13–48 months). The
average duration of follow-up was 73.3±35.4 months after
HSCT (23 studies, n=321 patients, range across studies
10.5-134.4 months). The donor source that was used for
HSCT treatment was described by 16 studies; eight had
included multiple donor types, four used cord blood
transplantations only, three were confined to unrelated
donors, and one to related donors. The success rate of
HSCT was described by 14 papers, with full engraftment at
the first attempt in on average 76% of the cases (range 47-
100%). In the following sections, the motor functioning/
longitudinal growth and musculoskeletal manifestations of
Hurler’s disease will be addressed separately (section 3.2
and 3.3 respectively). Note that prevalence data were
calculated based on subgroup analyses, with average group
sizes of 55 patients (range 21–107) for motor functioning
(Table 3A), 48 (range 7–103) for the musculoskeletal
manifestations (Table 3B), and 88 (range 7–170) for the
surgical interventions (Table 3C).
Motor functioning and longitudinal growth of Hurler
patients after HSCT
With increasing life expectancy in Hurler’s disease, recent
research activities have focussed their attention on everyday
functioning. Gait and independent mobility are important




University of Minnesota, Minneapolis, U.S.A. 8 210
University of North Carolina, Chapel Hill, U.S.A 3 41
Westminster Children’s Hospital, London, U.K. 3 17
Our Lady`s Hospital for Sick Children, Dublin, Ireland 2 31
Royal Manchester Children’s Hospital, Manchester, U.K. 2 22
Hôpital Debrousse, Lyon, France 2 20
Karolinska University Hospital, Stockholm, Sweden 2 10
Children’s Hospital and Franciscan Hospital for children, Boston, U.S.A. 2 2
Duke University Medical Center, Durham, U.S.A. 1 17
University of Kentucky Medical Center, Lexington, U.S.A. 1 11
University of California, San Francisco, U.S.A. 1 7
Children’s Hospital, Hannover Medical School, Hannover, Germany 1 5
Children’s Hospital, North Adelaide, Australia 1 3
Hôpital Neurologique, Lyon, France 1 1
University of Western Ontario, London, Canada 1 1
Pellenberg University Hospital, Lubbeek, Belgium 1 1
Total 32 399
Table 1 Institutes at which the
included studies were conducted
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aspects of everyday motor functioning. A total of nine
studies, including 81 patients investigated gait in Hurler’s
disease (see also Table 3A). All of these studies addressed
one of three aspects of gait: 1) development of independent
walking in toddlers, 2) quality of gait, and 3) independent
gait and mobility in late childhood/ adolescence. With
respect to independent walking, four studies reported a
delayed onset (Hugh-Jones 1986; Dusing et al. 2007a;
Ringden et al. 2006; Dusing et al. 2007b). This develop-
mental delay was attributed to limited practice during
hospitalisation for HSCT, in addition to orthopaedic
abnormalities (Dusing et al. 2007a). The second aspect of
gait, quality of gait, has recently been addressed by Dusing
et al. in a group of 18 patients (Dusing et al. 2007a). The
patients had reduced walking speed, shortened step length,
and increased energy expenditure early in life. Yet, walking
speed and step length normalised by the age of 4 years. The
third aspect of gait concerned the preservation of indepen-
dent gait (see also Table 3A). While the majority of patients
remained mobile, independent unaided gait was lost in 12
patients (24.5%), at a mean follow-up of 72.6 months after
HSCT, predominantly due to orthopaedic complications
such as severe genu valgum and hip dislocation.
Other aspects that contribute to motor functioning are the
development of gross and fine motor skills. These were
generally studied on a group level, using developmental
scales such as the Vineland Adaptive Behavior Scales
(VABS) (Bjoraker et al. 2006), Peabody Developmental
Motor Scales, edition 2 (PDMS-2) (Dusing et al. 2007a;
Dusing et al. 2007b; Dusing et al. 2005), Denver
Developmental Screening Test (DDST) (Lucke et al.
2007), and the more recently developed MPS-PPM (MPS
physical performance measure) (Dumas et al. 2004).
Evaluation of these five studies, including a total of 63
patients, showed that Hurler patients were limited in their
gross motor development and had mild to pronounced
motor retardation between 0 and 4 years of age, when
compared to age-referenced controls. However, the limi-
tations in a group of 41 treated Hurler patients were milder
as compared to a cross-sectional group of 43 non-treated
patients (Bjoraker et al. 2006). Not surprisingly, the degree
of motor development was associated with the age and
developmental status of the patients at the time of HSCT,
such that the younger and less affected patients had a better
developmental outcome (Bjoraker et al. 2006).
On the topic of fine motor skills, specifically hand
dexterity, individual patient data were available (see
Table 3A). Although age-referenced hand function im-
proved after HSCT treatment (Hugh-Jones 1986; Lucke et
al. 2007), 88.5% of the patients still showed impairments in
comparison to healthy children. These impairments were
partly caused by comorbidities such as CTS (Malm et al.
2008b), trigger fingers (Weisstein et al. 2004) and spinal
cord compression (Kachur and Del Maestro 2000), and for
the other part by bony abnormalities such as broad stubby
digits.
Limitations in joint range of motion (ROM), especially
of the upper extremity, were another main feature of
Hurler’s disease (prevalence 94.5%, see Table 3A). Al-
though positive effects of HSCT on joint ROM were
consistently reported, joint mobility in treated Hurler
patients remained limited (Field et al. 1994; Hugh-Jones
1986; Weisstein et al. 2004; Fleming et al. 1998; Guffon et
al. 1998). Fixed flexion contractures of the lower extremity
were occasionally reported in the older literature, when
surgical interventions of progressive hip subluxation and
genu valgum were postponed (Field et al. 1994).
Although some authors have optimistically reported nor-
malised longitudinal growth following HSCT (Hugh-Jones
1986), growth rates appeared compromised at long term
follow-up. A total of nine studies, including 107 patients,
have reported growth details. A height below 2SD of the
average is generally considered abnormal. Information on
the number of patients shorter than -2SD was provided
by 58 patient reports. A total of 51.7% of these patients
had short stature, with a mean follow-up of 80.2 months
after HSCT. The linear growth of Hurler patients was
associated with the age at HSCT (Souillet et al. 2003;
Polgreen et al. 2008; Vellodi et al. 1997), such that a
younger age at HSCT resulted in a larger height. High
enzyme levels following HSCT, and conditioning regi-
mens for HSCT without total body irradiation were also
associated with a larger height (Polgreen et al. 2008). In
general, the growth rate of Hurler patients remained
 Exclusion based on 
title and abstract: 107 
Additional inclusion after 
contacting the authors: 1  
Additional inclusion after 
reference tracking: 3  
Embase search: 225 hits Pubmed search: 206 hits  
Articles screened full text: 99 
Articles included: 26  
Total inclusion: 32 articles 
Articles screened full text: 5 
Articles included: 2  
 Exclusion based on 
title and abstract: 95 
 Exclusion of 
duplicates: 125 
Fig. 1 Flow chart of included
studies
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1986 Hugh-Jones 5 19.6 37.8 Kyphosis, gait, hand dexterity, joint ROM, growth
1993 Belani 30 C1-2 instability, odontoid dysplasia, cord compression,
neurological symptoms
1993 Hopwood 3 13 > 120 Kyphosis, hip dislocation, genu valgum, CTS, gait, joint ROM
and surgical procedures *
1994 Bona 1 CTS (surgery)
1994 Field 11 19.5 111 Kyphosis, hip dysplasia, genu valgum, CTS, joint ROM, growth
and surgical procedures
1996 Masterson 8 9 28 Hip dysplasia (surgery), gait
1996 Tandon 12 16 54 C1-2 instability, odontoid dysplasia, soft tissue deposition, cord
compression, vertebral abnormalities, kyphosis (surgery),
scoliosis, disc abnormalities, spondylolisthesis, neurological
symptoms
1997 Vellodi 10 17 134.4 C1-2 instability, odontoid hypoplasia, soft tissue deposition,
cord compression, kyphosis, hip dysplasia, gait, motor
development, hand dexterity, growth and surgical procedures
1998 Flemming 11 20 60 Joint ROM
1998 Guffon 9 60 Kyphosis, hip dysplasia, genu valgum, CTS, joint ROM, growth
and surgical procedures
1998 van Heest 15 21 CTS and trigger finger surgery
1999 Odunusi 17 19 Genu valgum (surgery)
2000 Hite 8 20 104.4 Odontoid hypoplasia, soft tissue deposition, cord compression
2000 Kachur 1 24 72 Cord compression (surgery), soft tissue deposition, kyphosis,
genu valgum, neurological symptoms, hand dexterity, muscle
strength
2001 Dalvie 1 48 12 Kyphosis (surgery)
2003 Souillet 11 24.2 90 C1-2 instability, kyphosis, scoliosis, genu valgum, hip
dysplasia, CTS, joint ROM, muscle strength, growth and
surgical procedures
2004 Dumas 1 Gait, motor development
2004 Staba 17 18 54 Kyphosis, growth and surgical procedures
2004 Weisstein 7 20 55.2 C1-2 instability, soft tissue deposition, vertebral and disc
abnormalities, kyphosis, hip dysplasia, genu valgum, CTS and
trigger fingers, neurological symptoms, hand dexterity, joint
ROM and surgical procedures
2005 Dusing 2 22.5 10.5 Motor development, hand dexterity, kyphosis, hip dislocation
2005 van Meir 1 CTS and kyphosis surgery
2006 Bjoraker 41 21.7 67.2 Motor development
2006 Ringdén 4 < 20 Kyphosis (surgery), hip dislocation, gait, neurological
symptoms
2007 Dusing 21 17.1 16.2 Motor development, genu valgum
2007 Dusing 18 18.8 29.9 Gait
2007 Khanna 43 19 103.2 CTS (surgery)
2007 Lucke 5 25 46 Motor development, hand dexterity
2008 Malm 6 18 67.2 Hip dysplasia, CTS, neurological symptoms, hand dexterity,
growth and surgical procedures
2008 Polgreen 48 20 83 Growth
2008 Taylor 23 9.4 102 Kyphosis, scoliosis, genu valgum, hip dysplasia, gait, joint
ROM, muscle strength, growth and surgical procedures
2009 Polgreen 8 Kyphosis, genu valgum and surgical procedures
2009 Rebello 1 Hip dysplasia (surgery)
HSCT=hematopoietic stem cell transplantation, ROM=range of motion, CTS=carpal tunnel syndrome
* Surgical procedures are not further specified in the current table
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Gait / mobility 9 81 *
Unaided, independent gait 6 49 12 (24.5) 20.0 72.6
ROM hip, knee, shoulder, elbow 7 55 52 (94.5) 20.6 92.0
Longitudinal growth 9 107 *
Growth < −2SD of normal 5 58 30 (51.7) 20.0 80.2
Sitting height/ trunk growth 2 21 *
Motor development 5 63 *
Hand dexterity 7 26 23 (88.5) 20.8 50.1
Neurological symptoms 7 61 12 (19.7) 20.6 48.5
Muscle strength 3 45 *
B. Musculoskeletal manifestations
I. Radiological signs
X-ray of cervical spine
C1-2 instability 5 70 14 (20.0) 19.2 84.2
Odontoid hypoplasia 4 60 43 (71.7) 17.4 94.2
MRI of cervical spine
Soft tissue deposition
around odontoid
5 28 24 (85.7) 17.9 97.8
Spinal cord compression 5 59 4 (6.8) 18.8 100.0
Ligamentous hypertrophy 3 19 6 (31.6) 20.1 107.7
X-ray or MRI of thoracolumbar spine
Vertebral abnormalities 3 30 28 (93.3) 18.2 75.2
Kyphosis 14 101 82 (81.2) 16.6 80.0
Scoliosis 3 46 15 (32.6) 14.7 86.6
Spondylolisthesis 1 12 10 (83.3) 16.0 54.0
Disc abnormalities 2 10 3 (30.0) 16.8 54.2
X-knee
Genu valgum 9 103 72 (69.9) 16.4 74.2
Dysplasia of proximal
tibial metaphysis
2 34 23 (67.6) 12.7 104.9
X-hip
Hip dysplasia 8 67 60 (89.6) 15.4 84.4
Hip dislocation/ (sub)luxation 8 32 13 (40.6) 14.4 54.5
II. Hand involvement
Carpal tunnel syndrome 7 90 57 (63.3) 18.4 90.7
Trigger fingers 1 7 4 (57.1) 20.0 55.2
C. Surgical interventions
Treatment
Cervical fusion 5 45 5 (11.1) 20.6 97.2
Spinal cord decompression 2 17 3 (17.6) 18.2 101.8
Thoracolumbar spinal fusion 14 170 55 (32.4) 16.5 86.2
Knee surgery 8 140 51 (36.4) 16.0 80.0
Hip containment surgery 9 101 46 (45.5) 16.1 84.2
Carpal tunnel release 12 141 79 (56.0) 19.1 93.2
Trigger finger release 1 7 4 (57.1) 20.0 55.2
HSCT=hematopoietic stem cell transplantation, ROM=range of motion, SD=standard deviation
*=limited data available on the number of affected patients; available group data will be discussed in the results section
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normal for several years, after which it gradually
decreased. For example, Vellodi et al. showed that the
average height of 10 patients reached -2SD at an age of
6 years (Vellodi et al. 1997). The decreased growth was
largely attributable to a reduced trunk growth with an
average sitting height below 3SD at 8 years of age, and
below 4SD at 12 years of age (corresponding subischial
leg length of 0 SD and – 2 SD respectively).
Motor functioning in Hurler’s disease was further
compromised by neurological comorbidities. A total of
seven papers, including 61 patients, documented the
neurological status of the patients. Neurological complica-
tions were observed in 19.7% of the patients, consisting of
increased intracranial pressure (n=4), a tethered cord
(n=2), signs of spinal cord or cauda compression (n=4)
and abnormal neurological leg functioning (n=3). Reduced
muscle strength was generally not found (Souillet et al.
2003; Field et al. 1994), although one report described mild
proximal weakness of the legs (Taylor et al. 2008).
Musculoskeletal manifestations of Hurler’s
disease - prevalence
The prevalence of the main orthopaedic and radiological
signs of Hurler’s disease is depicted in Table 3B. In the
following section, these orthopaedic signs will be addressed
separately.
Spine Cervical involvement was frequently reported in
Hurler’s disease. In particular, a failure of ossification of
the odontoid process (odontoid dysplasia or hypoplasia),
which was identified in 71.7% of the patients (Vellodi et
al. 1997; Belani et al. 1993; Hite et al. 2000; Tandon et al.
1996). Somewhat remarkably, the odontoid dysplasia
appeared to respond favourably to HSCT treatment
(improvement of moderate/severe to mild dysplasia in 10
patients) (Hite et al. 2000; Tandon et al. 1996). Soft tissue
depositions around the odontoid process were found in
85.7% of the patients, and 31.6% showed hypertrophy of
the longitudinal ligaments (Weisstein et al. 2004; Kachur
and Del Maestro 2000; Vellodi et al. 1997; Hite et al.
2000; Tandon et al. 1996). These cervical manifestations
may result in potentially life-threatening atlantoaxial
instability and spinal cord compression. Yet, in the Hurler
population these symptoms were relatively rare. Atlan-
toaxial instability, based on flexion-extension X-rays, was
identified in 20% of the patients (Souillet et al. 2003;
Weisstein et al. 2004; Vellodi et al. 1997; Belani et al.
1993; Tandon et al. 1996). Cervical spinal cord compres-
sion, predominantly based on MRI imaging, was observed
in only 3.4% (2 cases) (Kachur and Del Maestro 2000;
Vellodi et al. 1997; Belani et al. 1993; Hite et al. 2000;
Tandon et al. 1996).
One of the other key features of spinal involvement in
Hurler’s disease is the thoracolumbar kyphosis or gibbus
deformity, which was observed in 81% of the patients (see
also Table 3B). The thoracolumbar kyphosis usually
develops at the level of L1-L2, and has been observed as
early as birth (Cleary and Wraith 1995; Dusing et al. 2005).
Failure of ossification of the anterior superior aspect of the
vertebral body, i.e. beaking, was observed in 93.3% of the
patients (Table 3B). Spondylolisthesis was frequently
observed as well, with thinning and elongation of the
pedicles, hypoplasia of the facet joints and scalloping of the
posterior border of the vertebrae (Weisstein et al. 2004;
Tandon et al. 1996). Only two studies reported disc space
narrowing (three affected patients, prevalence 30%). Thor-
acolumbar spinal cord compression was also rare and
documented for two patients (prevalence 3.4%) (Weisstein
et al. 2004; Tandon et al. 1996). Although not as common
as kyphosis, scoliosis was relatively common in Hurler
patients as well (prevalence 32.6%). In 53% of the scoliosis
patients, scoliosis was observed in combination with
kyphosis.
Hips Another predeliction site for the failure of primary
ossification in Hurler’s disease was the acetabulum, resulting
in acetabular dysplasia with subsequent hip lateralisation and
(sub)luxation. A total of eight articles including 67 patients
addressed acetabular dysplasia, with a prevalence of 89.6%.
Early arthrography consistently revealed a non-ossified
cartilaginous acetabular roof, with a centrally ossified femoral
head (Field et al. 1994; Taylor et al. 2008; Masterson et al.
1996), sometimes in combination with an eversion of the
acetabular labrum (Masterson et al. 1996). Acetabular
dysplasia was not necessarily associated with dislocation of
the hip (dislocation present in 40.6% of the patients). In
order to quantify the degree of acetabular dysplasia, several
methods have been used. Especially for patients undergoing
surgery, measures of the MEA (mean acetabular angle), CEA
(centre-edge angle), and the extrusion index have been
documented (Weisstein et al. 2004; Taylor et al. 2008;
Masterson et al. 1996; Rebello et al. 2009). On average,
MEA scores ranged from 36° pre-operatively to 20° post-
operatively (n=27 patients). In addition to acetabular
dysplasia, coxa valga and thinning of the femoral epiphysis
were consistently shown as well (n=8 (100%) and n=42
(100%) respectively) (Field et al. 1994; Taylor et al. 2008;
Masterson et al. 1996).
Knees Failure of ossification was also observed for the
lateral margin of the proximal tibial metaphysis, resulting in
progressive genu valgum. A total of 103 patient reports on
genu valgum showed a prevalence of 69.9%. Genu valgum
was usually defined as a tibial femoral shaft angle of>7°,
with an average pre-operative angle of 17.9° (angular data
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for only n=13 patients). It was predominantly identified
between 2 and 5 years of age (Odunusi et al. 1999).
Spontaneous regression was not observed, and progression
has been associated with severe functional limitations
(Field et al. 1994).
Hands The prevalence of carpal tunnel syndrome (CTS), as
identified from seven papers including 90 patients, was
63.3% (see Table 3B). The compression of the median
nerve was caused by GAG deposition in the flexor
retinaculum, in combination with skeletal deformities (Field
et al. 1994; Van Heest et al. 1998). The development of
CTS was directly associated with the age of the patients at
HSCT, with each year prior to HSCT leading to a 58%
increase in the risk of developing CTS (Khanna et al.
2007). The development of CTS seemed also related to the
enzyme activity after HSCT, since all patients with low
enzyme activity in the study of Khanna et al. developed
CTS (Khanna et al. 2007). Additional limitations in hand
dexterity might originate from the development of trigger
fingers with flexion deformities. Reports on the prevalence
of trigger fingers were limited (one paper, seven patients)
with a prevalence of 57.1% (Weisstein et al. 2004).
Musculoskeletal manifestations of Hurler’s
disease – orthopaedic management
Most authors recommended early surgical intervention in
Hurler’s disease (Field et al. 1994; Weisstein et al. 2004;
Taylor et al. 2008; Masterson et al. 1996; Odunusi et al.
1999). Yet, timing and type of surgery greatly varied.
Table 3C shows the prevalence of the various surgical
interventions. Table 4 summarizes their subtypes and
outcomes. The average age at which Hurler patients
underwent surgery is depicted in Table 5. A total of 252
reports on orthopaedic surgeries were identified, with 163
reports on treatment outcome. In the past, cardiopulmonary
complications such as difficult intubation and coronary
obstruction have led to several intra-operative deaths in
Hurler patients (Belani et al. 1993). Improved anaesthetic
techniques and increased knowledge have reduced the risk
of such intra-operative complications (Ard et al. 2005;
Martins et al. 2009). With regard to the orthopaedic
outcome, the overall complication rate was 13.5% (22
affected patients). Yet, some treatments had complication
rates up to 42.9% (thoracolumbar bracing, n=6 / isolated
femoral osteotomy, n=6) and 56.3% (epiphyseal stapling,
n=9). Surgical failure was generally not due to non-union,
as bone-healing showed normal callus formation and union
(Field et al. 1994). In the following section, the subtypes
and outcomes of the various surgical interventions will be
further elaborated on.
Spine Surgical treatments for cervical instability and spinal
cord compression were relatively rare in Hurler’s disease,
with a prevalence of 11.1% and 17.6% respectively (see
also Table 3C). In the case of cervical instability, both
occiput-C2 and C1-C2 fusions were performed (see
Table 4). The outcome was discussed for only one patient
with a temporary non-union following an occiput-C2
fusion, due to suboptimal immobilisation after surgery
(Minerva brace) (Weisstein et al. 2004). For cervical cord
compression, successful laminectomies have been de-
scribed. Yet, further details on the surgical technique were
lacking.
The orthopaedic treatment of thoracolumbar kyphosis
appeared to be contentious with respect to both timing and
type of intervention. For mild cases of kyphosis (i.e an angle
below 40°) treatment was often postponed. Spontaneous
improvement of mild kyphosis was observed in 15.2% of
the patients (7 cases) (Weisstein et al. 2004; Staba et al. 2004).
In addition, 21 cases of stable mild kyphosis were described
(Souillet et al. 2003; Weisstein et al. 2004; Taylor et al. 2008;
Staba et al. 2004). It must be mentioned, however, that
follow-up periods for these patients did not extend into
adolescence. In the case of progression or anticipated
progression of kyphosis, some authors have attempted
bracing (Souillet et al. 2003; Guffon et al. 1998; Taylor et
al. 2008; Tandon et al. 1996). The outcome of bracing was
variable, with ongoing progression of the kyphotic angle in
42.9% of the patients (six cases, see also Table 4).
When the kyphotic angle progressed, surgical inter-
vention was often required. The pre-operative Cobbs
angle was on average 58.8° (angular data for only 4
patients). Furthermore, spinal cord compression, as
observed in two cases, was a clear indication for surgery.
Spinal fusion was performed in 32.4% of the patients,
with an average follow-up duration of 86 months after
HSCT (see Table 3C). The average age at spinal fusion
was 5.9 years (see Table 5). For the surgical correction of
kyphosis, both anterior and posterior short segment
fusions were described, as well as their combination. As
appears from Table 4, no adverse outcomes were reported
for any of the techniques.
Hips Hip containment surgery as a treatment for hip
dysplasia was common in Hurler patients (prevalence
45.5%, see Table 3C). The average age at surgery was
7.4 years (see Table 4 and 5). Several techniques have been
attempted, such as an isolated femoral osteotomy, an
isolated pelvic osteotomy and a combination of both
techniques. As is shown in Table 4, isolated femoral
osteotomies have resulted in a large percentage of failure
(42.9%, n=6) due to the absence of acetabular remodelling
after surgery, requiring revision surgery (Field et al. 1994;
Vellodi et al. 1997; Taylor et al. 2008). Therefore, a
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combination of a pelvic and femoral osteotomy was
attempted instead, in 19 patients. The latter technique
showed good results, with no reported adverse outcomes
(Souillet et al. 2003; Weisstein et al. 2004; Taylor et al.
2008; Masterson et al. 1996). More recently, it has been
shown that an isolated pelvic osteotomy without an
additional femoral osteotomy, performed in 8 patients,
was sufficient to contain proper femoral head coverage as
well (Ringden et al. 2006; Weisstein et al. 2004; Taylor et
al. 2008; Masterson et al. 1996).
Knees Genu valgum usually occurred between 2 and 5 years
of age (Odunusi et al. 1999). Since spontaneous improvement
was generally not observed, a surgical correction was carried
out in a considerable amount of patients (36.4%, see
Table 3C). The most common type of surgery was a
temporary hemi-epiphysiodesis by medial epiphyseal sta-
pling (Table 4), performed at an average age of 7.7 years
(Table 5). Complications were reported for 56.3% of the
patients (n=9) (Taylor et al. 2008; Odunusi et al. 1999). The
majority of adverse outcomes were related to the dislodge-














O-C2 fusion 3 3 1 100% * Non- union (Minerva brace)
C1-2 fusion 1 1
Cervical fusion, NFS 1 1
Total 5 5
Cord compression
Cervical laminectomy 2 2 2 0%
Thoracal laminectomy 1 2
Total 3 4
Kyphosis
Anterior fusion 2 3 1 0% *
Posterior fusion 3 12 6 0%
Ant+post fusion 1 1
Spinal fusion, NFS 9 39 6 0%
Bracing 5 16 14 42.9% Progression of kyphosis
Total 15 58
Genu valgum




Surgery, NFS 1 26
Total 9 51
Hip dysplasia
Isolated femoral osteotomy 5 16 14 42.9% No acetabular remodelling
Isolated pelvic osteotomy 4 8 8 0%
Femoral+pelvic osteotomy 5 19 17 0%
Surgery, NFS 2 39
Total 15 46
Carpal tunnel syndrome
Soft tissue release 13 80 70 1.4% No improvement of NCV
Trigger digits
Soft tissue release 3 10 8 0%
Overall total 63 252 163 13.5%
NFS=not further specified, NCV=nerve conduction velocity
* Note that these percentages are based on a single patient report
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ment of staples due to the use of suboptimal materials
(barbed stainless steel), rather than by MPS I disease
characteristics. Consequently, no complications have been
described after the introduction of new materials (barbed
vitallium staples) and the 8-plate (Taylor et al. 2008;
Odunusi et al. 1999). Genu valgum was also corrected by a
permanent hemi-epiphysiodesis in two patients. Since the
outcome of this technique largely depends on the (unpre-
dictable) appendicular growth of Hurler patients after
surgery, this technique has become obsolete.
Hands Surgical release of the carpal tunnel, with or without
additional tenosynovectomy of the flexor retinaculum, was
the most often reported musculoskeletal intervention in
Hurler patients (80 patient reports, Table 4; prevalence of
56%, Table 3C). A total of 70 patient reports on the
outcome of surgical release for CTS were identified (see
Table 4). Following surgery, muscle strength and EMG
findings considerably improved. Although these benefi-
cial effects have even been described for patients with
already severe nerve compression, surgical release pre-
sumably elicits better results if done early (Van Heest et
al. 1998). A lack of EMG improvements following
surgery was reported only once (1.4% of the cases
(Vellodi et al. 1997)).
Trigger fingers were reported less frequently, with only
ten descriptions of a surgical release in the current literature
(see Table 4). All trigger finger releases were performed in
conjunction with a CTS release. The techniques used, were
a resection of the A-1 with or without the A-3 pulley,
sometimes with an additional partial flexor digitorum
superficialis tendon resection (Van Heest et al. 1998). The
outcome was generally good, with no recurrences and
improved digital flexion and hand dexterity (Van Heest et
al. 1998).
Discussion and conclusion
The aim of the current study was to systematically review
the developmental and orthopaedic implications of Hurler’s
disease after treatment with HSCT. A considerable number
of papers (32) with a total of 399 relevant patient reports
were identified. Among these papers were only few
prospective studies (n=3) and no comparative studies. This
has led to great variability in the scoring methods used, and
carries the risk of a reporting bias. Another serious
limitation of the currently published material was the
relatively short follow-up period (on average 73.3 months
after HSCT). Consequently, long term perspectives can not
be given. Furthermore, the executed subgroup analyses
were based on varying sample sizes, ranging from 7–170
patients. Nevertheless, the quantification of the prevalence
and treatment of the various musculoskeletal complications,
as currently given, may enhance the insights in the
orthopaedic treatment of Hurler’s disease.
The most frequently reported musculoskeletal manifes-
tations of Hurler’s disease after HSCT were odontoid
hypoplasia, thoracolumbar kyphosis, genu valgum, hip
dysplasia and carpal tunnel syndrome. Motor functioning
was further compromised by reduced joint mobility, hand
dexterity, motor skills, longitudinal growth, and neurolog-
ical comorbidities. Although the positive effects of HSCT
on the musculoskeletal manifestations of Hurler’s disease
were limited, improvements in joint mobility, motor skills,
odontoid dysplasia, carpal tunnel syndrome and longitudi-
nal growth were identified (Field et al. 1994; Hugh-Jones
1986; Weisstein et al. 2004; Fleming et al. 1998; Guffon et
al. 1998; Hite et al. 2000). The improvements in joint
mobility have been attributed to a reduction in GAG
accumulation in the relatively well vascularised synovium,
following the availability of donor enzyme in the blood
(Breider et al. 1989). The improved joint mobility in
addition to overall improvements in neuro-cognitive devel-
opment might, in turn, explain the improved gross and fine
motor skills of treated Hurler patients (Peters and Steward
2003). The etiology behind the improvement of the
odontoid process deserves further attention, as it appears
to be the only responsive endochondral bone (Hite et al.
2000; Tandon et al. 1996).
With regard to the positive effects of HSCT treatment,
early timing seems favourable (Souillet et al. 2003;




Total number of operated
patients with age reference
Cervical fusion 9.3 [7–12] 3
Spinal cord decompression 8 [8] 1
Thoracolumbar spinal fusion 5.9 [3.5-9.3] 22
Epiphyseal stapling 7.7 [6.5-11] 9
Hip containment surgery 7.4 [4.4-8.6] 18
Carpal tunnel release 5.4 [3.4-9.3] 57
Trigger finger release 6.9 [6.9] 4
Table 5 Average age of Hurler
patients at surgery
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Bjoraker et al. 2006; Polgreen et al. 2008; Vellodi et al.
1997; Hite et al. 2000; Khanna et al. 2007). However, even
early treatment cannot prevent dysostosis multiplex, pre-
sumably because many ossification defects have already
developed prior to HSCT treatment. For example, kyphosis
and hip dysplasia often appear at birth (Cleary and Wraith
1995; Ringden et al. 2006; Dusing et al. 2005; Malm et al.
2008a). Besides insufficient GAG clearance, further pro-
gression of the musculoskeletal abnormalities may be due
to early irreversible changes both in the growth plate and
the tendoligamentous complex responsible for load transfer
and stability.
Although the natural course of the musculoskeletal
manifestations of Hurler’s disease after HSCT remains
largely unknown, an active approach towards the orthopae-
dic management of these patients seems warranted, due to
the irreversible and progressive nature of their deficiencies.
Since various surgeries are often performed in the first
decade of life, a combination of surgeries, for example of
the hip and knee, is advocated (Odunusi et al. 1999).
Unfortunately, prospective data on treatment outcome were
lacking, making it impossible to determine possibly
associated factors such as age, degree of deformity and
weight bearing status at the time of treatment. Nevertheless,
some general recommendations regarding the orthopaedic
management and follow-up of Hurler patients may be
formulated based on the currently published literature.
Cervical spine abnormalities are a major concern, since
they might result in potentially life-threatening atlantoaxial
instability and spinal cord compression, as has been
frequently described in mucopolysaccharidosis type IV
(MPS IV, Morquio’s disease) and type VI (MPS VI,
Maroteaux-Lamy) (Hughes et al. 1997; Thorne et al.
2001). In the Hurler population these symptoms were
relatively rare. One of the reasons might be that odontoid
dysplasia responded favourably to HSCT treatment (Hite et
al. 2000; Tandon et al. 1996). Nevertheless, annual follow-
up with MRI imaging should be considered. In order to
treat atlantoaxial instability, it is currently not clear whether
occipito-cervical fusions should be favoured above C1-C2
fusions.
Regarding the thoracolumbar kyphosis, various hypoth-
eses on the pathogenesis have been posted. Swischuk
(1970) suggested that it resulted from a combination of
poor muscle tone, altered weight-bearing forces, growth
abnormalities and disc herniation (Swischuk 1970). More
recent findings point towards an important role of failure of
ossification of the anterior superior aspect of the vertebral
body (Field et al. 1994; Weisstein et al. 2004; Tandon et al.
1996). Bracing therapy might be considered especially in
patients who are too young for surgery (Tandon et al. 1996;
White and Harmatz 2010). Yet, the effectiveness remains
largely unknown due to limited follow-up data and lack of
information on the natural course of kyphosis in Hurler’s
disease. In the current literature, surgical intervention for
progressive kyphosis was performed at a relatively young
age (5.9 years). The decision to surgically intervene largely
depended on the angle of kyphosis and the related risk of
progression. The average pre-operative Cobbs angle of the
Hurler patients (58.8°) was consistent with general guide-
lines for spinal fusion (Cobbs angle exceeding 60°) (Arlet
and Schlenzka 2005). Both anterior and posterior short
segment fusions might be considered. Although no adverse
outcomes were reported for any of the techniques, personal
communications imply that posterior fusion alone may lead
to failure and the need of re-operation (White and Harmatz
2010). Clinical experience with anterior fusion, in contrast,
seems promising, with no failures in a period of 10 years
(personal communication with Dr. H. Noordeen, Great
Ormond Street Hospital for Children, London, UK).
Hip dysplasia was found in the majority of Hurler
patients. Yet, it should be noticed that the femoral head
appeared well contained within the non-ossified lateral
acetabular roof in many (Field et al. 1994; Taylor et al.
2008; Masterson et al. 1996). Nevertheless, nearly half of
the patients underwent hip containment surgery. A typical
feature of Hurler’s disease appeared to be the failure of
acetabular remodelling following an isolated femoral
osteotomy. Consequently, an osteotomy of the pelvis (with
or without additional femoral osteotomy) is favoured above
an isolated femoral osteotomy in Hurler patients.
Progressive genu valgum occurred in the majority of
patients and should be treated surgically because of the
disabling consequences. Genu valgum was often treated
by a temporary hemi-epiphyseodesis in the form of
medial epiphyseal stapling. In children under 6 years,
stapling as well as the 8-plate are difficult due to the
small size of the epiphysis. In contrast, epiphyseal
stapling may no longer be sufficient if the angular
deformity of the knee is too large (Odunusi et al.
1999). Consequently, most patients are treated between
6–8 years of age. With respect to surgical intervention, a
large percentage of adverse outcomes was observed due to
the use of a suboptimal materials. After the introduction of
new materials, adverse outcomes were no longer observed
(Taylor et al. 2008; Odunusi et al. 1999).
With respect to carpal tunnel syndrome, an aggressive
approach seems warranted. Early recognition is important,
since surgical release can prevent adverse outcomes with
muscle wasting, flexion contractures of the fingers, sec-
ondary bony changes and subsequent reduction in hand
dexterity (Field et al. 1994; Souillet et al. 2003; Weisstein et
al. 2004; Guffon et al. 1998; Vellodi et al. 1997; Van Heest
et al. 1998; Khanna et al. 2007; Van Meir and De Smet
2005; Bona et al. 1994). Because classical symptoms such
as numbness, tingling and nocturnal pain are often lacking
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(Van Heest et al. 1998), annual EMG testing is advisable.
When a soft tissue release for CTS is performed, intra-
operative inspection of the tendons of the fingers is
indicated.
To conclude, stem cell transplantation has yielded
enormous improvements in the therapy of Hurler’s
disease and patients are now surviving into adulthood.
In order to benefit optimally from HSCT treatment, early
timing is favourable. Consequently, the diagnostic delay
should be reduced below the currently reported 9 months
(Cleary and Wraith 1995). Since the skeletal abnormali-
ties (especially the thoracolumbar kyphosis) account for~
40% of the presenting signs and are often present at birth
(Cleary and Wraith 1995), orthopaedic surgeons should
play an important role in earlier diagnosis. Early surgical
treatment is advocated and seems warranted, due to the
limited response of the skeletal abnormalities to HSCT and
their progressive and irreversible nature. However, prospec-
tive studies using standardised data collection are mandatory
to further optimise the orthopaedic management of these
patients.
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